Stockholders’ Equity of the Company

At-The-Market Stock Offering Program

During the three months ended June 30, 2018, the Company completed its existing at-the-market stock offering program, under which we sold an aggregate of $300.0 million in gross sales of shares. In June 2018, the Company commenced a new at-the-market stock offering program (the “2018 At-The-Market Program”), under which we may currently offer and sell shares of our common stock with an aggregate gross sales price of up to $500.0 million. In connection with the 2018 At-The-Market-Program, the Company also entered into related forward purchase agreements whereby, at our discretion, we may sell shares of our common stock under the 2018 At-The-Market-Program under forward equity sales agreements. The use of a forward equity sales agreement would allow the Company to lock in a share price on the sale of shares of our common stock at the time the agreement is executed, but defer receiving the proceeds from the sale of shares until a later date. This also allows us to defer the potential dilutive impact of such offering of shares until such time as we settle the forward equity sales agreement.

Since commencement of our 2018 At-The-Market Program in June 2018, we have sold 349,466 shares of common stock through June 30, 2018, none of which were sold under forward equity sales agreements. Approximately $473.4 million remains available to be sold under this program.

The following table sets forth information regarding sales of common stock under our at-the-market offering programs for the six months ended June 30, 2018:



	Six Months Ended June 30, 2018
	(in millions, except share and per share data)
Shares of common stock sold during the period	1,719,195
Weighted average price per common share	$	73.66
Aggregate gross proceeds	$	126.6
Aggregate net proceeds after selling commissions	$	125.1

The proceeds from sales were used to fund acquisitions, development expenditures and general corporate purposes. Actual future sales will depend upon a variety of factors, including but not limited to, market conditions, the trading price of the Company’s common stock and our capital needs. We have no obligation to sell the remaining shares available for sale under this program.